In clinical specimens of HNSCC, the overexpression of PXN mediated by HPV E6 drives tumor progression and correlates with inferior disease-free survival, recurrence-free survival, and overall survival rates (Hefni et al., 2023; Wu et al., 2014; Zhao et al., 2020). The gene discussed is PXN; the disease is neoplasm.